Effect of Hejie decoction on T cell immune state of chronic hepatitis B patients

Table 1 ALT, AST, TB and HBVDNA levels before and after treatment (mean ± SD)

		n	ALT (U/L)	AST (U/L)	TB (μmol/L)	HBVDNA (copy/mL)
Normal		10	27.80 ± 8.65	19.07 ± 8.50	12.55 ± 5.52	0
Treatment	Pre-T	40	213.66 ± 10.30	134.66 ± 9.82	41.03 ± 4.36	(1.52 ± 0.72) × 108.25
	Post-T	40	37.01 ± 9.75b	29.07 ± 8.97b	20.55 ± 5.52b	(4.25 ± 1.90) × 106.02 a
Control	Pre-T	25	195.70 ± 11.11	125.12 ± 9.21	40.87 ± 6.78	(1.32 ± 0.89) × 108.12
	Post-T	25	36.01 ± 9.75b	69.88 ± 8.97b	30.55 ± 5.52b	(6.95 ± 2.39) × 107.82

n: Number; normal: Normal group; treatment: Treatment group; control: Control group; Pre-T: Before treatment; Post-T: After treatment; ^aP < 0.05, vs before treatment in the same group, ^bP < 0.01, vs before treatment in the same group.